Long-Term Synaptic Depression: Clinical Trials

15 trials of Long-Term Synaptic Depression, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 4 unknown, 1 not yet recruiting, 1 recruiting. 15 Phase 2, 4 Phase 3, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 215Completed 9, Unknown 4, Not yet recruiting 1, Recruiting 1
Phase 34Completed 3, Not yet recruiting 1
Phase 13Completed 3

Follow Long-Term Synaptic Depression: new trials by email Literature Review of Long-Term Synaptic Depression trials Research Report on Long-Term Synaptic Depression

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bovis Calculus Stativus Treat Acute Cerebral Ischemic Stroke With Impaired Consciousness
Bovis Calculus Stativus (BCS), Placebo - Acute Ischemic Stroke AIS, Impaired Consciousness
Phase 2 / Phase 3Not yet recruitingXiang Luo2202025-12-152025-12-18
Tirofiban After Successful MT Recanalization in AIS
Tirofiban, Saline placebo - Acute Ischemic Stroke, Vessel Occlusion
Phase 2 / Phase 3CompletedXiang Luo13802024-04-092026-03-11
Research of SORD-CMT Natural History and Epalrestat Treatment
Epalrestat - Charcot-Marie-Tooth Disease (CMT)
Phase 2UnknownThe Third Xiangya Hospital of Central South University302023-04-012023-04-18
Carrelizumab Combined With Chemotherapy for Adjuvant Therapy of Esophageal Squamous Cell Carcinoma
Camrelizumab, Paclitaxel, Cisplatin - Esophagus Cancer
Phase 2UnknownTianjin Medical University Cancer Institute and Hospital232020-11-262022-12-05
Effectiveness of Recombinant Human Growth Hormone Therapy for Children With PMS
recombinant human growth hormone, Saline - Phelan-McDermid Syndrome, Growth Hormone Treatment
Phase 1 / Phase 2CompletedAffiliated Hospital of Jiangnan University62020-06-142022-10-10
Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA
gemcitabine and oxaliplatin., Afatinib - Gallbladder Carcinoma
Phase 2RecruitingShanghai Jiao Tong University School of Medicine1022020-06-012024-10-16
Efficacy and Safety of Lidocaine Infusion Treatment in Management of Neuropathic Pain
Lidocaine HCl, Normal saline - Postherpetic Neuralgia, Diabetic Polyneuropathy
Phase 2UnknownSeoul National University Hospital442015-08-012015-11-05
No Treatment Versus Oral Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants
Oral ibuprofen, Normal saline - Bronchopulmonary Dysplasia (BPD)
Phase 2CompletedSamsung Medical Center1422014-07-012020-01-13
Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) in Patients With Advanced Gastric Cancer
S-1, leucovorin, oxaliplatin - Gastric Cancer
Phase 2UnknownJilin Provincial Tumor Hospital492013-11-012015-03-05
Efficiency of Placental Drug MelsmonĀ® in Correction of Climacteric Symptoms in Premenopausal Women
Melsmon, Placebo - Climacteric Syndrome
Phase 2 / Phase 3CompletedInna I. Kovalenko402013-10-012016-04-25
Use of a Novel Fibrin Sealant in Total Knee Arthroplasty
Evicel Fibrin Spray - Osteoarthritis, Intraoperative Bleeding
Phase 2 / Phase 3CompletedRush University Medical Center732012-05-012016-02-09
Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic Stroke
Dl-3-n-butylphthalide, Cerebrolysin, Placebo - Acute Cerebral Stroke Within 12 Hours for the First Time
Phase 1 / Phase 2CompletedShanghai 6th People's Hospital842010-01-012020-08-24
Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China
S-1, leucovorin, oxaliplatin - Colorectal Cancer
Phase 1 / Phase 2CompletedShen Lin202009-09-012015-05-19
Efficacy of Udenafil After Radical Resection for Sigmoid Colon and Rectal Cancer
Udenafil - Erectile Dysfunction, Sigmoid Colon Cancer
Phase 2CompletedSeoul National University Hospital462009-03-012012-09-05
Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver Injury
Magnesium Isoglycyrrhizinate Injection 100mg OD, Magnesium Isoglycyrrhizinate Injection 200mg OD, Tiopronin Injection - Drug-Induced Liver Injury
Phase 2CompletedChia Tai Tianqing Pharmaceutical Group Co., Ltd.1742007-12-012016-09-27

Conditions studied

Ischemic Stroke (3)  ·  Blood Loss, Surgical (1)  ·  Bronchopulmonary Dysplasia (1)  ·  Charcot-Marie-Tooth Disease (1)  ·  Chemical and Drug Induced Liver Injury (1)  ·  Colorectal Neoplasms (1)  ·  Diabetic Neuropathies (1)  ·  Ductus Arteriosus, Patent (1)  ·  Erectile Dysfunction (1)  ·  Esophageal Neoplasms (1)  ·  Gallbladder Neoplasms (1)  ·  Hemorrhage (1)  ·  Neuralgia, Postherpetic (1)  ·  Osteoarthritis (1)  ·  Peripheral Nervous System Diseases (1)

Sponsors

Seoul National University Hospital (2)  ·  Xiang Luo (2)  ·  Affiliated Hospital of Jiangnan University (1)  ·  Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)  ·  Inna I. Kovalenko (1)  ·  Jilin Provincial Tumor Hospital (1)  ·  Rush University Medical Center (1)  ·  Samsung Medical Center (1)  ·  Shanghai 6th People's Hospital (1)  ·  Shanghai Jiao Tong University School of Medicine (1)  ·  Shen Lin (1)  ·  The Third Xiangya Hospital of Central South University (1)  ·  Tianjin Medical University Cancer Institute and Hospital (1)

Countries

China (8)  ·  South Korea (3)  ·  Russia (1)  ·  United States (1)

Top investigators

Brett R Levine, MD (1)  ·  Larisa V. Suturina, M.D. (1)  ·  Lixia Xue, M.D., Ph.D. (1)  ·  Minde Zeng, MD (1)  ·  Peng Tang, archiater (1)  ·  Se In Sung, M.D. (1)  ·  Sung-Bum Kang, M.D., Ph.D (1)  ·  Xiang Luo (1)  ·  Xiang Luo, PhD MD (1)  ·  Yingbin Liu, PHD (1)  ·  Yong Chul Kim, PhD (1)  ·  YueYing Liu, Phd (1)

Results publications

PMID 10565650, PMID 11679600, PMID 26158159, PMID 27168844, PMID 29381569, PMID 32539121, PMID 36854604, PMID 41991238, PMID 42341797